New Zealand Professional Investment Services Firm, Forsyth Barr

Forsyth Barr

New Zealand Professional Investment Services Firm

We are proud to be a New Zealand owned firm, with 21 offices throughout the country and over 300 employees. We assist personal, institutional and corporate clients providing a full range of investment services.

Forsyth Barr is a foundation New Zealand Exchange firm (NZX) and accredited market participant. We have been confirmed by the Financial Markets Authority as a Qualifying Financial Entity (QFE).

Research is the cornerstone of our advice. We have one of New Zealand's leading teams of analysts. Our global affiliations ensure comprehensive research coverage of all major investment markets.

Equity Bottom-Up

<ul>
<li>The a2 Milk Company (ATM) will report its FY26 result on Monday, 17 August 2026.</li>
<li>ATM noted a ‘large proportion’ of its China-label customers were forced to switch brands due to inadequate supply in 4Q26.</li>
<li>We look for an update on ATM’s Pokeno facility, where we expect utilisation to ramp up significantly in FY27.</li>
</ul>


The a2 Milk Company (ATM) will report its FY26 result on Monday, 17 August 2026.
ATM noted a ‘large proportion’ of its China-label customers were forced to switch brands due to inadequate supply in 4Q26.
We look for an update on ATM’s Pokeno facility, where we expect utilisation to ramp up significantly in FY27.


The a2 Milk Company FY26 Preview—Supply Restored

India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India Equity Analyst - Fundamental & Thematic

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

<ul>
<li>Sudeep Pharma, a mineral excipients and speciality ingredients maker, delivered FY26 revenue of INR 642.3 crore and PAT of INR 174.3 crore, though EBITDA margin declined.</li>
<li>Specialty Ingredients now contributes 44% of revenue, while Nandesari expansion, NSS Europe integration and Dahej battery-materials plant create the next growth levers.</li>
<li>Future performance depends on margin recovery, working-capital control, faster customer approvals at Nandesari and execution of the INR 300 crore battery materials project.</li>
</ul>


Sudeep Pharma, a mineral excipients and speciality ingredients maker, delivered FY26 revenue of INR 642.3 crore and PAT of INR 174.3 crore, though EBITDA margin declined.
Specialty Ingredients now contributes 44% of revenue, while Nandesari expansion, NSS Europe integration and Dahej battery-materials plant create the next growth levers.
Future performance depends on margin recovery, working-capital control, faster customer approvals at Nandesari and execution of the INR 300 crore battery materials project.


Sudeep Pharma: Building From Specialty Ingredients to Battery Materials

<ul><li>The a2 Milk Company (ATM) provided a positive update on its supply chain and FY26 guidance.</li><li>As a result, product flows to distributors and retailers have materially improved, and stock levels for both English Label and China Label have returned to targeted levels.</li><li>With uncertainty still relatively elevated and ATM now trading on a 12-month forward PE of ~28x, broadly in line with history, we continue to see a balanced risk–reward profile.</li></ul>

The a2 Milk Company (ATM) provided a positive update on its supply chain and FY26 guidance.As a result, product flows to distributors and retailers have materially improved, and stock levels for both English Label and China Label have returned to targeted levels.With uncertainty still relatively elevated and ATM now trading on a 12-month forward PE of ~28x, broadly in line with history, we continue to see a balanced risk–reward profile.

<ul><li>The a2 Milk Company (ATM) has announced the voluntary recall of three batches of a2 Platinum infant formula sold into the United States (US) due to the detection of cereulide.</li><li>The direct financial impacts of the recall are immaterial.</li><li>It is difficult to assess what impact (if any) the recall will have for ATM's sales in China, but we see Danone's January recall as the most relevant precedent given the shared root cause (cereulide) and the absence of direct product withdrawals in China.</li></ul>

The a2 Milk Company (ATM) has announced the voluntary recall of three batches of a2 Platinum infant formula sold into the United States (US) due to the detection of cereulide.The direct financial impacts of the recall are immaterial.It is difficult to assess what impact (if any) the recall will have for ATM's sales in China, but we see Danone's January recall as the most relevant precedent given the shared root cause (cereulide) and the absence of direct product withdrawals in China.

The a2 Milk Company US Infant Formula Recall

<ul><li>The a2 Milk Company (ATM) has announced the voluntary recall of three batches of a2 Platinum infant formula sold into the USA.</li><li>No confirmed incidents of illness or harm have been reported at this stage, but ATM is communicating with US consumers around recommended actions if they have purchased the product.</li><li>The direct financial impact of the recall is immaterial to ATM, with total US infant formula sales ~0.1% of revenue in 1H26.</li></ul>

The a2 Milk Company (ATM) has announced the voluntary recall of three batches of a2 Platinum infant formula sold into the USA.No confirmed incidents of illness or harm have been reported at this stage, but ATM is communicating with US consumers around recommended actions if they have purchased the product.The direct financial impact of the recall is immaterial to ATM, with total US infant formula sales ~0.1% of revenue in 1H26.

The a2 Milk Company (ATM): US Infant Formula Recall

France

Danone operates as a food processing company. The Company produces and markets dairy products, beverages, baby food, and medical nutrition products. Danone serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Danone (DANOY US)

The a2 Milk Company FY26 Preview—Supply Restored

The a2 Milk Company (ATM) will report its FY26 result on Monday, 17 August 2026. ATM noted a ‘large proportion’ of its China-label customers were...

Forsyth Barr

Sudeep Pharma: Building From Specialty Ingredients to Battery Materials

Sudeep Pharma reports strong FY26 revenue and PAT, with focus on specialty ingredients and growth levers for the future. Margin recovery and...

Sudarshan Bhandari

The a2 Milk Company Bottlenecks Breaking

The a2 Milk Company (ATM) provided a positive update on its supply chain and FY26 guidance. As a result, product flows to distributors and...

Forsyth Barr

The a2 Milk Company US Infant Formula Recall

The a2 Milk Company (ATM) has announced the voluntary recall of three batches of a2 Platinum infant formula sold into the United States (US) due...

Forsyth Barr

The a2 Milk Company (ATM): US Infant Formula Recall

The a2 Milk Company (ATM) has announced the voluntary recall of three batches of a2 Platinum infant formula sold into the USA. No confirmed...

Forsyth Barr

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

The a2 Milk Company FY26 Preview—Supply Restored

The a2 Milk Company (ATM) will report its FY26 result on Monday, 17 August 2026. ATM noted a ‘large proportion’ of its China-label customers were...

Forsyth Barr

Sudeep Pharma: Building From Specialty Ingredients to Battery Materials

​Sudeep Pharma reports strong FY26 revenue and PAT, with focus on specialty ingredients and growth levers for the future. Margin recovery and...

Sudarshan Bhandari

The a2 Milk Company Bottlenecks Breaking

The a2 Milk Company (ATM) provided a positive update on its supply chain and FY26 guidance. As a result, product flows to distributors and...

Forsyth Barr

The a2 Milk Company US Infant Formula Recall

The a2 Milk Company (ATM) has announced the voluntary recall of three batches of a2 Platinum infant formula sold into the United States (US) due...

Forsyth Barr

The a2 Milk Company (ATM): US Infant Formula Recall

The a2 Milk Company (ATM) has announced the voluntary recall of three batches of a2 Platinum infant formula sold into the USA. No confirmed...

Forsyth Barr

Sudeep Pharma reports strong FY26 revenue and PAT, with focus on specialty ingredients and growth levers for the future. Margin recovery and...